Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...
The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings.
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
Use of either fluticasone propionate or budesonide is suggested for patients with EoE treated with topical steroids. An empiric food elimination diet is suggested for EoE treatment, but currently ...
Hosted on MSN2mon
Environmentally Friendlier COPD Inhaler May Also Be More EffectiveBoth budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol provide the guideline-recommended combination of inhaled corticosteroid-long acting muscarinic antagonist (LAMA ...
In conclusion, the salmeterol/FP combination product (50/100µg twice daily) was at least as effective as a four-fold higher dose of BUD (400µg twice daily), with superior and more rapid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback